Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Dynavax Technologies (DVAX)
Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,834,069
  • Shares Outstanding, K 128,797
  • Annual Sales, $ 722,680 K
  • Annual Income, $ 293,160 K
  • 60-Month Beta 1.52
  • Price/Sales 2.51
  • Price/Cash Flow 5.89
  • Price/Book 3.02
Trade DVAX with:

Options Overview Details

View History
  • Implied Volatility 42.05% ( -1.51%)
  • Historical Volatility 26.94%
  • IV Percentile 38%
  • IV Rank 21.43%
  • IV High 82.63% on 02/14/23
  • IV Low 30.98% on 06/13/23
  • Put/Call Vol Ratio 0.01
  • Today's Volume 69
  • Volume Avg (30-Day) 337
  • Put/Call OI Ratio 0.23
  • Today's Open Interest 7,830
  • Open Int (30-Day) 11,773

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate -0.01
  • Number of Estimates 3
  • High Estimate 0.03
  • Low Estimate -0.07
  • Prior Year 0.43
  • Growth Rate Est. (year over year) -102.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.18 +9.98%
on 09/11/23
14.93 -2.95%
on 08/28/23
-0.25 (-1.70%)
since 08/25/23
3-Month
12.27 +18.09%
on 07/06/23
15.12 -4.17%
on 08/08/23
+1.46 (+11.20%)
since 06/27/23
52-Week
9.42 +53.82%
on 03/17/23
15.12 -4.17%
on 08/08/23
+4.04 (+38.66%)
since 09/27/22

Most Recent Stories

More News
Dynavax to Present at the H.C. Wainwright 25th Annual Global Investment Conference

/PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative...

DVAX : 14.49 (+1.76%)
Dynavax Technologies (DVAX) Q2 2023 Earnings Call Transcript

DVAX earnings call for the period ending June 30, 2023.

DVAX : 14.49 (+1.76%)
Dynavax Technologies: Q2 Earnings Snapshot

Dynavax Technologies: Q2 Earnings Snapshot

DVAX : 14.49 (+1.76%)
Dynavax Reports Second Quarter 2023 Financial Results and Raises Full Year Revenue Guidance

/PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative...

DVAX : 14.49 (+1.76%)
Dynavax to Report Second Quarter 2023 Financial Results and Host Conference Call on August 3, 2023

/PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative...

DVAX : 14.49 (+1.76%)
Dynavax to Present at Upcoming Investor Conferences

/PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative...

DVAX : 14.49 (+1.76%)
Dynavax to Present at the JMP Securities Life Sciences Conference

/PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative...

DVAX : 14.49 (+1.76%)
Dynavax Technologies (DVAX) Q1 2023 Earnings Call Transcript

DVAX earnings call for the period ending March 31, 2023.

DVAX : 14.49 (+1.76%)
Dynavax Technologies (DVAX) Reports Q1 Loss, Tops Revenue Estimates

Dynavax Technologies (DVAX) delivered earnings and revenue surprises of -58.33% and 21.35%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

DVAX : 14.49 (+1.76%)
ITOS : 11.51 (+1.32%)
Dynavax Technologies: Q1 Earnings Snapshot

Dynavax Technologies: Q1 Earnings Snapshot

DVAX : 14.49 (+1.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax's clinical development...

See More

Key Turning Points

3rd Resistance Point 14.84
2nd Resistance Point 14.70
1st Resistance Point 14.60
Last Price 14.49
1st Support Level 14.36
2nd Support Level 14.22
3rd Support Level 14.12

See More

52-Week High 15.12
Last Price 14.49
Fibonacci 61.8% 12.94
Fibonacci 50% 12.27
Fibonacci 38.2% 11.60
52-Week Low 9.42

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar